View Report
October 1, 2025
Batch: BPCGA8
Measured Result 5.17 mg 103.4% of label claim
Peptide Hubs
Peptide Hubs
Latest Laboratory Result 5.17 mg October 1, 2025 · 103.4% of label claim View
You will save $15.20
BPC 157 5 mg
Product Information Compound Details
Active Substance Pentadecapeptide BPC 157 (Body Protection Compound)
5 mg/vialStrength 5 mg/vial
Package 1 Vial
Form Lyophilized Powder
Vial Size 2 mL Vial
Drug Class Research Peptide
Manufacturer Peptide Hubs
$22.80
$38.00
Shipping :
International
U.S. Domestic
Product Overview
BPC 157 5 mg by Peptide Hubs
BPC 157 5 mg is a lyophilized pentadecapeptide research product manufactured by Peptide Hubs and supplied as a 5 mg/vial powder in a 2 mL vial.
Pentadecapeptide Injectable
BPC 157 5 mg contains the synthetic pentadecapeptide known as Body Protection Compound 157 (BPC-157), a 15-amino-acid sequence derived from a protective protein found in human gastric juice. The peptide has been studied extensively in preclinical models for its effects on tissue repair and recovery processes, with research suggesting it may enhance growth hormone receptor expression in tendon fibroblasts.
In preclinical research settings, BPC-157 has been observed to influence pathways associated with angiogenesis (new blood vessel formation), fibroblast activity, and cellular protection across various tissue types. These properties have generated interest in both academic research and non-medical bodybuilding communities, where it is commonly referenced for tendon, ligament, and muscle recovery support. However, BPC-157 is not FDA-approved for any human indication and carries a Category 2 bulk drug substance restriction.
Human clinical evidence for BPC-157 remains extremely limited. A 2026 review noted that only three uncontrolled pilot studies with a combined sample size of 30 participants have been reported, with no validated pharmacokinetics or long-term safety data. A Phase 2 clinical trial evaluating BPC-157 for acute hamstring muscle strain repair began in 2026, but results are not yet available.
Key Benefits of BPC 157 5 mg
- Pentadecapeptide sequence associated with tissue repair pathways
- Lyophilized powder format for reconstitution flexibility
- Studied in preclinical models for angiogenesis and cytoprotection
- 5 mg per vial for research and non-medical protocols
- Manufactured by Peptide Hubs
Formulation
Lyophilized Powder
BPC 157 5 mg is supplied as a lyophilized (freeze-dried) powder in a 2 mL vial. Reconstitution with an appropriate solvent is required before use in research or non-medical contexts.
Product Profile
Pentadecapeptide Profile
BPC-157 is a stable gastric pentadecapeptide with the amino acid sequence GEPPPGKPADDAGLV and a molecular weight of approximately 1,419 Da.
Research Peptide
BPC-157 belongs to a class of synthetic peptides investigated for cytoprotective and tissue-repair properties. Unlike classic anabolic steroids, it does not act through androgen receptor pathways; its proposed mechanisms involve modulation of angiogenesis, growth factor expression, and the nitric oxide system.
Preclinical research has demonstrated that BPC-157 can up-regulate growth hormone receptor expression in tendon fibroblasts, potentially potentiating the proliferative effects of growth hormone on healing tissue. The peptide has also been shown to activate VEGFR2-Akt-eNOS signaling, promoting angiogenesis in ischemic tissue models.
In non-medical bodybuilding contexts, BPC-157 is commonly referenced for localized soft-tissue recovery, particularly for tendon, ligament, and muscle injuries, though such use lacks rigorous clinical validation and falls outside approved indications.
Defining Characteristic
Pentadecapeptide Sequence
BPC-157 is a synthetic 15-amino-acid fragment derived from a protective protein found in human gastric juice. This short sequence is the basis for its classification as a pentadecapeptide and distinguishes it from longer peptides such as TB-500.
BPC 157 5 mg vs Other Peptide Hubs Preparations
Peptide Hubs offers a range of research peptides and performance compounds. Within this lineup, BPC-157 is often discussed alongside TB 500, another research peptide commonly referenced for recovery purposes, though the two have distinct amino acid sequences and mechanisms.
For those exploring peptide-based recovery protocols, GHK-CU represents a different approach, focusing on copper-binding peptide activity rather than BPC-157's angiogenic and cytoprotective pathways. For research requiring a reconstitution solution, Bacteriostatic Water is the standard diluent for preparing lyophilized peptides like BPC 157 5 mg.
Laboratory Testing
BPC 157 5 mg Lab Reports
Published laboratory reports for BPC 157 5 mg are shown below with the test date, measured content, and batch number.
View Report
View Report
April 22, 2025
Measured Result 5.09 mg 101.8% of label claim
Laboratory results apply to the specific tested sample represented in each published report and should not be interpreted as a measurement of every vial or production batch.
Dosage & Usage
BPC 157 5 mg Dosage & Usage
The information below is provided for educational reference only. BPC-157 is not an FDA-approved human drug. Its use for performance, recovery, or any non-medical purpose falls outside approved indications, and no established human dosing regimen exists.
Typical Dosage Ranges
Because BPC-157 lacks human pharmacokinetic data and FDA approval, there is no medically established dosage range. In non-medical bodybuilding and research communities, reference ranges are derived from animal studies and anecdotal reports, with substantial uncertainty. Commonly referenced ranges in community discussions are 250–500 mcg per day for subcutaneous administration, with some protocols referencing up to 500 mcg twice daily for acute injuries.
| Use Case | Common Reference Range | Injection Frequency |
|---|---|---|
| General recovery support (non-medical) | 250 mcg | Once or twice daily |
| Acute injury protocol (non-medical) | 500 mcg | Once or twice daily |
| Combined with TB-500 (non-medical) | 250–500 mcg BPC-157 + TB-500 | Per individual protocol |
These ranges are community conventions, not evidence-based medical recommendations. No human dose-response relationship has been established, and individual response is unpredictable.
Reconstitution & Handling
BPC 157 5 mg is supplied as a lyophilized powder and requires reconstitution before use. In non-medical contexts, bacteriostatic water is commonly used as the solvent. A 5 mg vial reconstituted with 2 mL of solvent yields a concentration of 2.5 mg/mL (2,500 mcg/mL), meaning a 250 mcg dose would require drawing 0.1 mL (10 units on a U-100 insulin syringe).
Reconstituted peptide should be stored refrigerated at 2-8°C and used within approximately four weeks. Lyophilized powder is more stable and should be kept under appropriate conditions.
Stacking & Cycle Considerations
In non-medical bodybuilding contexts, BPC-157 is frequently combined with TB 500 for recovery-focused protocols, as the two peptides are believed to address complementary aspects of tissue repair. Cycle lengths commonly referenced range from 4 to 6 weeks on, followed by 2 to 4 weeks off.
For those seeking to combine BPC 157 5 mg with growth hormone support, Ipamorelin is sometimes referenced in community protocols, though this represents a combination of different mechanisms rather than a validated synergistic stack.
Important
Individual Response Varies
No human pharmacokinetic or dose-response data exists for BPC-157. All dosage information is derived from animal research or community convention and should not be interpreted as medical guidance.
Safety & Information
Pentadecapeptide Safety Information
BPC-157 is not FDA-approved for human use. Safety data in humans is extremely limited, and non-medical use carries unknown risks.
Important Safety Information
BPC-157 has been evaluated by the FDA for inclusion on the 503A bulk drug substances list and was found not to meet the criteria for compounding, with the agency citing insufficient clinical safety information, inconsistent naming conventions, and lack of characterization data. In 2022, BPC-157 was added to the World Anti-Doping Agency Prohibited List under S0 (Non-Approved Substances).
There are no FDA-approved drug products containing BPC-157. Its status as a research peptide means it has not undergone the rigorous clinical trials required for human pharmaceutical approval.
Important
Non-Medical Use
BPC-157 is marketed in the United States as a research chemical, but it has not been established as safe or effective for any human indication. Non-medical use falls outside approved indications.
Potential Adverse Effects
Human safety data for BPC-157 is minimal. Community-reported side effects include injection site reactions (redness, soreness, swelling), nausea (more common with oral dosing), dizziness, headache, and fatigue. These reports are anecdotal and not from controlled trials.
As a peptide administered parenterally, BPC-157 may pose immunogenicity risks. The FDA has noted potential for enhanced immunogenicity, along with minimal establishment of purity, efficacy, or safety. Theoretical concerns include angiogenic effects in the presence of undiagnosed tumors, though causation in humans is unproven.
Conditions Requiring Medical Evaluation
Given the absence of human safety data, any consideration of BPC-157 use should involve consultation with a qualified healthcare professional. Individuals with active malignancy or a history of cancer should exercise particular caution due to the peptide's pro-angiogenic properties. Those taking anticoagulants or with bleeding disorders should also be cautious.
Monitoring During Use
No established monitoring protocol exists for BPC-157. In research contexts, any adverse reactions should be documented and reported to appropriate authorities.
Product Care
Storage & Handling
Lyophilized powder should be stored under conditions that preserve peptide stability. Protect from heat, moisture, and light. Once reconstituted, store refrigerated at 2-8°C and use within approximately four weeks. Keep out of reach of children.
Further Safety Information
Shipping & Authenticity
Shipping & Product Authenticity
BPC 157 5 mg is supplied through the official Peptide Hubs distribution chain and shipped in original manufacturer packaging with discreet handling.
USA Domestic 3–5 business days
International 10–15 business days
Order Processing 24–48 business hours
Tracking Provided after dispatch
Direct Supply
Discreet Delivery & Original Packaging
The outer shipping package remains discreet, with privacy-focused handling. Products are supplied through the official Peptide Hubs distribution chain.
What to Expect
- Orders are processed after payment confirmation
- USA Domestic shipping is typically faster when local stock is selected
- International orders include tracking, though update frequency may vary
- Multiple warehouses may result in separate shipments when applicable
Authenticity Verification
To verify your BPC 157 5 mg product, use the security code on the vial label and cross-check it on the Peptide Hubs official site. Original packaging and manufacturer presentation help reinforce product legitimacy.
For complete delivery details, tracking policy, and reshipment terms, please see our Shipping Info page.
Storage
BPC 157 5 mg Storage
Proper storage conditions help preserve peptide stability and integrity throughout shelf life.
Recommended Conditions
Store lyophilized powder sealed and protected from light and moisture. For longer-term storage, refrigeration or freezing of the unreconstituted powder may be appropriate, though specific stability data for this product is limited.
Once reconstituted, store refrigerated at 2-8°C and use within approximately four weeks. Avoid repeated temperature fluctuations.
Keep out of reach of children. Follow proper handling practices.
Quick Reference
Do & Don't
- Do store powder sealed and protected from light
- Do keep in original packaging until use
- Do refrigerate reconstituted solution at 2-8°C
- Don't expose to excessive heat or moisture
- Don't freeze reconstituted solution
- Don't use if solution appears cloudy or contains particles
Frequently Asked Questions
BPC 157 5 mg FAQ
Answers to common questions about BPC 157 5 mg, Pentadecapeptide, and research peptide handling.
What is BPC 157 5 mg used for?
BPC 157 5 mg is a research peptide studied in preclinical settings for its potential effects on tissue repair and recovery. In non-medical bodybuilding contexts, it is commonly referenced for tendon, ligament, and muscle recovery support, though such use falls outside approved indications and lacks rigorous clinical validation.
How often should BPC 157 5 mg be injected?
No established human dosing schedule exists. Community protocols commonly reference once or twice daily administration, but this is based on anecdotal convention rather than pharmacokinetic data.
Does BPC 157 5 mg require PCT?
BPC-157 does not suppress endogenous testosterone production and does not require post-cycle therapy in the way anabolic steroids do. However, any non-medical peptide use should be approached with caution given the absence of human safety data.
What does Pentadecapeptide do?
Pentadecapeptide refers to a peptide chain of fifteen amino acids. In the case of BPC-157, this specific sequence has been studied for effects on angiogenesis, growth hormone receptor expression, and cellular protection in animal models.
How long does BPC 157 5 mg take to work?
No human data establishes a timeline for effects. Preclinical research suggests some effects may occur within days in animal models, but translation to human timelines is speculative.
Is Pentadecapeptide the best recovery peptide?
There is no universally “best” research peptide. BPC-157 is one of several peptides studied for recovery-related properties, each with distinct mechanisms. Human comparative data is essentially absent.
What is the difference between BPC 157 5 mg and TB 500?
BPC-157 and TB-500 are different peptides with different amino acid sequences and proposed mechanisms. BPC-157 is a pentadecapeptide, while TB-500 is a fragment of thymosin beta-4. Both are commonly referenced in recovery contexts but are not interchangeable.
What is the difference between BPC 157 5 mg and GHK-CU?
GHK-CU is a copper-binding tripeptide studied for skin and wound-healing applications, while BPC-157 is a larger peptide studied for broader tissue repair. They operate through different proposed pathways.
Is 500 mcg of BPC 157 a lot?
Without human dose-response data, it is impossible to characterize any amount as appropriate or excessive. Community protocols commonly reference 250–500 mcg per day, but this is convention, not evidence.
What strength is BPC 157 5 mg?
BPC 157 5 mg is labeled at 5 mg of pentadecapeptide per vial. It is supplied as a lyophilized powder in a 2 mL vial.
Is BPC 157 5 mg lab tested?
Yes. The latest published laboratory report dated October 1, 2025 measured BPC 157 5 mg at 5.17 mg, equivalent to 103.4% of its 5 mg label claim. The batch number is BPCGA8.
How should BPC 157 5 mg be stored?
Store the lyophilized powder sealed and protected from light and moisture. Once reconstituted, refrigerate at 2-8°C and use within approximately four weeks.
Related Offers
Lab Tested
Domestic & International
-40% OFF
Peptide Hubs
Product Information Compound Details
Active Substance Thymosin Beta 4 TB-500 fragment (LKKTETQ region)
5 mg/vialStrength 5 mg/vial
Package 1 Vial 2 mL vial
Form Lyophilized Powder
Vial Size 2 mL Vial
Drug Class Research Peptide
Manufacturer Peptide Hubs
$24.00
$40.00
Lab Tested
Domestic & International
-40% OFF
Peptide Hubs
Product Information Compound Details
Active Formula TB 500 / BPC 157 Blend
10 mg/vialThymosin Beta 4 (TB-500 fragment) 5 mg
Body Protection Compound 157 5 mg
Total Strength 10 mg/vial
Package 1 Vial 2 mL vial
Form Lyophilized Powder
Vial Size 2 mL Vial
Drug Class Research Peptide
Manufacturer Peptide Hubs
$45.00
$75.00